4/A//SEC Filing
DARLING ALLAN JAMES 4/A
Accession 0001209191-03-017037
CIK 0001036629other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:43 PM ET
Size
9.2 KB
Accession
0001209191-03-017037
Insider Transaction Report
Form 4/AAmended
BIORELIANCE CORPBREL
DARLING ALLAN JAMES
VP, US Biologics Testing
Transactions
- Award
Employee Stock Options (Right to Buy)
2003-08-07+15,000→ 15,000 totalExercise: $21.24From: 2004-08-07Exp: 2013-08-07→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The original form mistakenly reported the price of the derivative securities as $21.24. This amendment amends the original form to reflect that the price of the derivative securities is zero dollars. The options reported on this form were granted under the Amended and Restated BioReliance 1997 Incentive Plan.
- [F2]These options vest according to the following schedule: (i)3,000 on 8/7/04, (ii)3,000 on 8/7/05, (iii)3,000 on 8/7/06, (iv)3,000 on 8/7/07, (v)3,000 on 8/7/08.
Documents
Issuer
BIORELIANCE CORP
CIK 0001036629
Entity typeother
Related Parties
1- filerCIK 0001255093
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 7:43 PM ET
- Size
- 9.2 KB